by Daniel X. Thomas
Patent EP 3 027 186 B1 relates to a process for the preparation of filler compositions comprising hyaluronic acid and mepivacaine hydrochloride, an anaesthetic agent.
Brief outline of the case
The OD found that claim 1 as granted lacked N over claim 36 of D2=WO 2012/104419, the first document cited in the ISR established by the EPO.
by Daniel X. Thomas
Patent EP 2 819 699 B1 relates to controlled release compositions and their method of use, and to low viscosity controlled release compositions for use in the treatment of mastitis in lactating animals.
Brief outline of the case
The OD decided that the new MR filed in opposition was infringing Art 123(2).
by Daniel X. Thomas
Patent EP 3 293 124 B1 relates to a high power packaging method and device, in particular for small pieces like pralines.
Brief outline of the case
The opponent appealed the rejection of its opposition.
In its decision the board held that claims 1 (method) and 9 (device) as granted lacked IS over D3=DE 10 2008 019 605+D1=US 4 947 617.
by Daniel X. Thomas
Brief outline of the case
The opponent appealed the rejection of its opposition.
In its decision the board held that claims 1 (method) and 9 (device) as granted lacked IS over D3=DE 10 2008 019 605+D1=US 4 947 617.
by Daniel X. Thomas
The patent relates to an agent for use in the prophylaxis or improvement of frailty in elderly person.
Brief outline of the case
The OD decided that claims 1 and 11 of the main request did not meet the requirements of Article 123(2). The same applied to AR1-7. Cl5 of AR8 was lacking clarity.